Medical Device News Magazine

Omar Hussain 30 Year Proven Leadership in the Healthcare Data Security Industry Is Appointed to Secure AI Labs Board of Directors

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

November 24, 2020

Omar Hussain is the former CEO of Imprivata. The news was announced today by Secure AI Labs.

“Omar Hussain’s background in scaling Imprivata from a startup to IPO brings invaluable and relevant strategic expertise to the table. We are looking forward to his help in building out a scalable, secure, and efficient solution for hospitals to maintain patient data privacy while contributing to healthcare innovation,” said SAIL CEO Anne Kim.

“I am delighted to have been appointed to the Board of Directors at SAIL and look forward to working with the team to achieve business objectives,” said Hussain. “Privacy and compliance regulations have done a great job of protecting patient data, but have always been a challenge in providing secure access for critical medical research. SAIL’s unique approach to leveraging digital rights management and federated learning is an exciting opportunity that brings tremendous benefits to hospitals.”

Hussain brings over 30 years’ worth of proven leadership experience in the healthcare data security industry. An experienced CEO and business development advisor, Hussain’s expertise includes product strategy, marketing, operations management, investor relations, and customer onboarding and retention. As the CEO of Imprivata, Hussain drove exponential growth that led to IPO and over $160 million in annual revenue. In 2013, Hussain was named Ernst and Young’s “Entrepreneur of the Year” in New England’s security and compliance category.

Secure AI Labs offers hospitals the digital rights management platform to maintain full ownership and control of their data when conducting research, federated machine learning, and other analysis. Following SAIL’s investments from Argon Ventures, E14 Fund, Asset Management Ventures, Two Lantern Venture Partners, and Drive Catalyst, expanding the advisory team positions the MIT-born startup for continued growth.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”